Greater Almería Metropolitan Area
I work at the intersection of synthetic biology, agrifood innovation and venture building, designing programmes and partnerships that move deep-tech ideas from lab to market. I like operating where science, business, policy and investment meet — aligning founders, researchers, corporates, investors and public institutions around concrete outcomes. Currently: • Head of the AgriTech Hub in El Ejido (Andalusia), a regional digital entrepreneurship centre in one of the world’s leading agrifood regions, promoted by the Andalusian Government and implemented by Impact Hub. I lead strategy and operations, co-design acceleration and high-performance programmes for 30+ start-ups, drive open innovation with agrifood players and connect founders with investors, venture builders and universities. • Founder & President of ATG SynBio Spain, the national synthetic biology association. I build the Spanish SynBio community, attract international partners and convene experts, investors and policymakers through initiatives with NATO and the NATO Innovation Fund, BIOSPAIN and the Microbial Engineering Symposium in Cambridge. • Provide innovation and technology transfer support to universities and research groups, helping scientists turn projects into spin-offs, licences and strategic collaborations, and advising on how to better connect academia with industry and investors. • Member of the External Expert Advisory Board for Agro4Agri, an EU project developing SynBio and bio-based solutions (biofertilisers, biostimulants, biopesticides) to reduce agrochemical dependency and support sustainable agriculture. Previously: • EC Deep Tech Incubation & Exploitation Expert at Da Vinci Labs on the €20M EIC-funded Seeds of Bravery initiative, incubating and accelerating 10+ Ukrainian deep-tech start-ups and organising the “Deep Tech for One Health” event in Paris. • Built early SynBio talent and community through iGEM (founding the first iGEM Málaga team), mentoring and speaking at international forums such as Grand Jamboree, Frontiers Health and leading bioeconomy events. • Started in biomedical research with a research internship at Karolinska Institutet, which gave me a rigorous scientific foundation and strong work ethic. What’s next? I want to keep operating at the frontier of SynBio and the bioeconomy, helping founders, research groups and institutions translate complex science into scalable, high-impact ventures and programmes across European and transatlantic SynBio hubs.
Director of the AgriTech Hub in El Ejido (Almería), located in one of the world’s leading agrifood regions: a physical coworking, training and events centre with specialised agricultural equipment, promoted by the Andalusian Government and implemented by Impact Hub as part of a new digital entrepreneurship model with regional impact across Andalusia. • Lead the hub’s strategy and day-to-day operations, integrating the coworking space, training offer and community events to support agrifood start-ups. • Co-design and manage the core programmes: an acceleration track (23 early-stage start-ups) and a high-performance track for more advanced ventures (7 start-ups), delivered through mentoring and consulting (on-site and online) from validation to go-to-market and investment readiness. • Drive open-innovation initiatives to address systemic challenges across the agrifood value chain, co-creating solutions with leading cooperatives and agrifood companies in Andalusia and Spain, technology providers, farmers’ organisations, individual farmers and investors. • Organise ecosystem-building activities, including C-level roundtables with major agrifood companies to accelerate technology adoption, sessions with farmers to increase awareness and readiness to adopt new solutions, and curated access for start-ups to investors and venture builders. • Collaborate on joint initiatives with other ecosystem actors, including the University of Almería and regional innovation projects, connecting talent, research and entrepreneurship.
ATG SynBio Spain is the Spanish synthetic biology association, advancing SynBio and bioentrepreneurship, promoting the bioeconomy, and connecting investors, startups, industry and policy makers. Key achievements • Collaboration with NATO on SynBio strategy (2025) Supported NATO’s Synthetic Biology strategic work by addressing key questions on dual-use risks, emerging technologies, and defence-relevant applications. Led the identification and mapping of European and US synthetic biology stakeholders and innovation ecosystems, providing structured input to inform strategic priorities. Facilitated targeted introductions and invitations of leading SynBio experts and organisations to NATO-related forums, including the NATO Innovation Fund’s participation in BIOSPAIN 2024 and the Microbial Engineering Symposium (Cambridge, 2025). Participated in the 1st NATO Biotechnology Conference (Brussels, 27 Oct 2025). • Microbial Engineering Symposium Cambridge 2025 (King’s College) Co-organized ATG’s first international event outside Spain, with 120+ participants from academia, startups, investors and policy. Secured sponsors including Twist Bioscience, CliniSciences, MicrobesNG, Novogene and EngBio IRC. Curated a programme on sustainable bioproduction, microbial biosensing, IP strategy, investment and policy, and moderated the panel “SynBio Playbook: IP, Investment & Scaling Strategy”. • Learning Expedition with the U.S. Navy SynBio & Biotech Director (2023) Coordinated a national SynBio mission across five Spanish cities to explore investment and collaboration opportunities, engaging 80+ stakeholders and organizing flagship events with PITA (Almería), Bioval/Generalitat Valenciana (Valencia) and CRG (Barcelona). • Designed and hosted “AI & SynBio: Shaping the Future of Healthcare” (Barcelona, 2024) and the International SynBio Congress (Barcelona, 2023), attracting international KOLs, VCs and 80+ stakeholders, and mobilising non-dilutive support for emerging SynBio startups.
Leading deal flow sourcing and opportunity assessment at Ivoro Ventures, working with universities, research centres and venture partners across Europe to identify and develop high-potential agrifood innovations. Ivoro Ventures is one of the venture builders selected to participate in the EIT Food Seedbed Venture Catalyst, where I act as a key interface with programme stakeholders, ensuring alignment, reporting on pipeline quality and supporting the progression of selected projects. Responsible for screening and evaluating opportunities from both technical and commercial perspectives, shaping investment-ready ventures across areas such as bio-based inputs, novel food, precision nutrition and climate-smart agriculture. Collaborating with partners to build a high-quality pipeline and apply a disciplined selection and structuring process, ensuring that only projects with strong venture potential advance toward company creation.
Member of the External Expert Advisory Board (EEAB) for Agro4Agri, an EU-funded consortium advancing bio-based solutions for sustainable agriculture. The project integrates synthetic biology, nanotechnology and RNAi technologies to develop next-generation biofertilizers, biostimulants and biopesticides. Responsible for providing strategic advice, reviewing work plans and key milestones, and assessing innovation outputs aimed at reducing agrochemical dependency, improving nutrient use efficiency and supporting environmentally friendly food systems aligned with EU sustainability policies.
• Managed a €200K budget within the €20M EIC-funded Seeds of Bravery initiative, supporting the Ukrainian deep tech ecosystem and its integration into the EU. • Incubated and accelerated 20+ deep tech startups, helping them scale by validating use cases, achieving product-market fit, refining business models, and developing Go-to-Market strategies. • Built strategic partnerships with investors (including CVCs), corporates, ecosystem KOLs, and policymakers to drive growth, secure private investment, and provide training on EIC funding instruments. • Organized Deep Tech for One Health (26/11/24, Paris), a high-impact event gathering 80+ stakeholders from startups, corporates, VCs, and policymakers, showcasing synthetic biology, AI & satellite, and quantum technologies.